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Abstract Mitochondria play an essential function in eukaryotic
life and death. They also play a central role in apoptosis
regulation, reflected by the convergence of Bcl-2 family members
on the mitochondrial outer membrane, and the presence of ‘death
factors’ in the intermembrane space. Mitochondrial structure and
function must be taken into consideration when evaluating
mechanisms for cytochrome c release. The core machinery for
caspase activation is conserved from Caenorhabditis elegans to
man, and we consider parallels in the role of mitochondria in this
process. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Mitochondria play a critical role in the control of apopto-
sis. In response to speci¢c stimuli they release cytochrome c,
which is a necessary cofactor for caspase activation by Apaf-
1. Mitochondria also sequester other pro-apoptotic factors.
The unique structure of this organelle is well understood in
the context of its function in electron transport and ATP syn-
thesis. However, the contribution of mitochondrial architec-
ture to cytochrome c release is less clear. Here, we consider
the role of mitochondria in regulation of apoptosis, and dis-
cuss the currently proposed models for cytochrome c release.
2. Mitochondrial architecture
Mitochondria are organized into several distinct spaces,
based on reconstructions of mitochondria imaged by electron
tomography [1,2]. The matrix is ¢lled with the enzymes of the
tricarboxylic acid cycle. Projecting through the matrix space
are hollow £attened or tubular structures, the cristae. The
crista membranes are continuous with the rest of the inner
mitochondrial membrane, and contain the electron transfer
complexes. The intermembrane space can be functionally sep-
arated into two compartments, the cristal lumen and the in-
termembrane space that lies between the inner membrane and
the outer membrane. It is estimated that 85^97% of the cyto-
chrome c resides in the cristal lumen, with the remainder in
the intermembrane space [3,4]. Cytochrome c is electrostati-
cally associated with cytochrome c reductase and cytochrome
oxidase, and is also associated with cardiolipin, which is
asymmetrically distributed across the lipid bilayer of the inner
membrane. Also present in the intermembrane space/cristal
lumen are procaspases 2, 3, and 9, and apoptosis initiating
factor (AIF) [5,6]. The points where cristae join the rest of the
inner membrane are termed crista junctions [2]. Crista junc-
tions are probably highly dynamic and should not be thought
of as rigid structures. Mannella et al. have observed that
under stress, the cristae can pinch o¡, thereby preventing
communication with the rest of the intermembrane space [7].
The F0F1 ATPase decorates the matrix side of the crista mem-
branes. The inner membrane/crista membrane is highly resis-
tant to proton leakage, allowing the buildup of a signi¢cant
membrane potential (about 3220 mV). The accumulated pro-
tons on the outer face of the inner membrane (in the lumen of
the cristae) leak back down their electrochemical gradient
through the F0F1 ATPase to drive ATP synthesis. Cardiolipin
is an anionic phospholipid that is only found in the mitochon-
drial inner membrane and is believed to contribute to the
proton-impermeable nature of the inner membrane.
The outer mitochondrial membrane is generally considered
to be permeable to small molecules (6 1000 Da) because of
the presence of a very abundant protein, the voltage-depen-
dent anion channel (VDAC). VDAC comprises as much as
20% of the protein of the outer membrane and is ordinarily
open. Bcl-2 is anchored in the outer mitochondrial membrane
and projects into the cytosol. Recent data point to an inter-
action between VDAC and Bcl-2 family members [8,9],
although this is controversial [10].
The outer membrane is dimpled with contact points where
the outer and inner membranes are closely juxtaposed. Con-
tact points may represent two di¡erent biochemical entities:
the protein translocation machinery made up of the translo-
case outer and inner membrane complexes (reviewed in [11]),
and the components of the nucleotide transport system, in-
cluding VDAC, the adenine nucleotide translocase (ANT),
and creatine kinase. These latter components are also constit-
uents of the permeability transition pore (PTP), whose open-
ing is often believed to herald mitochondrial destruction and
certain cell death. The PTP can be reconstituted with VDAC,
ANT, and cyclophilin D (reviewed in [12]). The association of
cyclophilin D with the PTP is important, as it underlies the
ability of cyclosporin A to prevent pore opening and mito-
chondrial dysfunction with cyclosporin A [13]. Additional
proteins that may co-purify with the PTP include hexokinase,
the peripheral benzodiazepine receptor, creatine kinase, and
Bax [14].
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3. Mechanisms of cytochrome c release
Because of the pivotal role of cytochrome c in caspase ac-
tivation, much e¡ort has been directed at delineating the
mechanism of its release from mitochondria during apoptosis.
Bcl-2 and related anti-apoptotic family members prevent its
release, while Bax and the BH3-only pro-apoptotic homologs
promote its release, perhaps by di¡erent mechanisms (recently
reviewed [15]). For the most part, pro-apoptotic homologs
reside in the cytosol, and in response to a stimulus, translocate
to the mitochondrial membrane, where they interact with oth-
er proteins to achieve cytochrome c release. For instance, Bad
is bound to protein 14-3-3 after phosphorylation. Dephos-
phorylation by protein phosphatase 1A or calcineurin permits
Fig. 1. A: Bax, the pore former. Bax forms oligomers which insert into the mitochondrial outer membrane to generate ion-conducting channels.
Dimerization with Bcl-2 or Bcl-xL prevents channel formation. In Tsujimoto’s model, shown on the right, Bax joins with VDAC to form large
channels. Bax inserts into the outer membrane and interacts with VDAC to form channels that are large enough to allow the passage of cyto-
chrome c. B: Bcl-2, friend of VDAC. Bcl-2 and Bax a¡ect VDAC to regulate ion conductance, including that of adenine nucleotides. Bcl-xL or
Bcl-2 could simply act as an ion channel to dissipate a potential across the outer membrane, permitting VDAC to remain open. Closure of
VDAC leads to accumulation of ATP in the intermembrane space, ANT distress, and matrix swelling, followed by rupture of the outer mem-
brane and cytochrome c release.
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its translocation to mitochondria [16,17]. Some studies suggest
that Bax translocates from cytosol to mitochondria while
others suggest that mitochondrial Bax undergoes a conforma-
tional change, which is enhanced by interaction with Bid [18^
20]. Bid is proteolysed by caspase 8 and the C-terminal por-
tion of the molecule interacts with the mitochondria, possibly
dependent on the presence of Bax [18,21,22]. Several models
for the mechanism of cytochrome c release have been pro-
posed, based on experimental evidence. They will be discussed
below.
Fig. 2. A: Bax, a component of the PTP. Bax joins forces with other constituents of the PTP (ANT and cyclophilin D (CypD)) to direct its
opening, leading to matrix swelling and compression of cristae (shown by arrows), and eventual rupture of the outer membrane and release of
cytochrome c (shown towards the right side of the diagram). B: Cytochrome c release is a two-step process. Truncated Bid (tBid) interacts
with the mitochondria to disturb (lightning bolt) the association of cytochrome c with the electron transfer complexes of the crista membranes.
Once dissociated (shown in middle crista), the cytochrome may interact with other death molecules, and will be free to di¡use into the cytosol
once the outer membrane is breached, perhaps by a permeability-enhancing factor or accessory protein (shown towards the right side of the di-
agram).
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3.1. Bax, the pore former
Because of the structural similarity of Bcl-xL to the pore-
forming bacterial diphtheria toxin, it was thought that Bcl-2
family members might function by acting as pores in the mi-
tochondrial outer membrane ([23] and reviewed in [24]). In-
deed, when inserted into arti¢cial lipid bilayers (after treat-
ment at pH 4), they do show ion conductance [25]. After
regulated cytochrome c release was described in 1996 [26], it
was hoped that the channels formed by Bax and friends might
be large enough to allow passage of cytochrome c (Fig. 1).
However, evidence in support of the notion that Bax might
form large multimers capable of passing a molecule of 12 000
Da has not been forthcoming.
3.2. Bax opens VDAC
Tsujimoto’s group provided evidence that Bax and VDAC,
when inserted into arti¢cial lipid bilayers, form high-conduc-
tance channels whose conductance is blocked by Bcl-xL [27].
More recent data have allowed them to re¢ne the model to
suggest that Bax interacts with VDAC to form a much larger
channel capable of accommodating cytochrome c (Fig. 1A)
[28].
3.3. Bcl-2, friend of VDAC
The ion conductance capacity of Bcl-2 has led Thompson
and coworkers [29] to propose that it may form an alternative
channel in the mitochondrial outer membrane that will permit
the transit of adenine nucleotides. They provide evidence to
show that apoptosis is associated with impaired mitochondrial
adenine nucleotide exchange, resulting in increased matrix
ATP and elevated levels of cytosolic ADP, which is prevented
by the expression of Bcl-2 or Bcl-xL [9,30]. Since nucleotides
ordinarily pass unimpeded through VDAC in the outer mem-
brane, they suspect that Bax may cause VDAC to close (Fig.
1B). The perturbation to nucleotide exchange is postulated to
lead to permeability transition and cytochrome c release.
3.4. Bax, a component of the PTP
Opening of the PTP has been proposed to lead to cyto-
chrome c release. The PTP is depicted in Fig. 2A. Opening
of the PTP permits in£ux of solutes 6 1500 Da, resulting in
depolarization of the inner membrane. Swelling of the matrix
and redistribution of the redundant cristal membranes may
lead to rupture of the outer membrane. Pore opening is regu-
lated by voltage, matrix pH, oxidative stress, electron £ow,
and by two of the pore constituents, cyclophilin D and ANT
([31,32], reviewed in [12]). Bax is thought to regulate the chan-
nel activity of the ANT [14,33]. A number of studies have
detected cytochrome c release in the absence of mitochondrial
depolarization or evidence of swelling [34^36]. PTP opening
and swelling does not represent a universal mechanism for
cytochrome c release but may play a role in some settings.
3.5. Cytochrome c release is preceded by dissociation
We found that cytochrome c ceased to participate in elec-
tron transfer early in apoptosis, before it could be detected in
the cytosol of cells disrupted by the gentle method of nitrogen
cavitation [37]. However, disruption of the outer mitochon-
drial membrane by homogenization could release the cyto-
chrome from mitochondria of apoptotic but not normal cells
[38]. Later in the course of apoptosis, the outer membrane was
disrupted and cytochrome c could be detected in cytosol.
These results indicate that cytochrome c dissociates from the
electron transfer chain ¢rst, and in a second step, passes
through the outer mitochondrial membrane (Fig. 2B). Trun-
cated Bid was shown to mediate the dissociation of cyto-
chrome c [22,39,40]. Recent evidence suggests that an acces-
sory factor may mediate permeability of the outer membrane
[41].
4. Mitochondria and caspases
Caspase activation is considered to be the sine qua non of
apoptosis. Both a receptor-mediated and a mitochondrial
pathway to caspase activation have been described and are
shown in Fig. 3. In the receptor-mediated pathway, Fas ligand
or tumor necrosis factor K binds to its receptor, causing re-
ceptor aggregation and recruitment of death adapter mole-
cules on the cytoplasmic side of the membrane. Procaspase
8 and/or 10 is recruited to the complex, where it can undergo
proximity-induced processing to the active form of a p20/p10
heterotetramer [42]. The activated caspase 8 (or 10) can then
cleave procaspase 3, which serves as an e⁄cient executioner to
cleave multiple targets within the cell, including caspase-acti-
vated DNase [43]. Caspase 8 also targets the mitochondria
through the proteolytic activation of Bid. The C-terminal
fragment translocates to the mitochondria, where it mediates
cytochrome c release. Although anti-apoptotic Bcl-2 family
members may prevent the ampli¢cation mediated by cyto-
chrome c release, they are generally ine¡ective at preventing
the direct activation of caspase 3 by caspase 8 after Fas liga-
tion [44]. This has led to a classi¢cation of cell lines as type I
or type II based on whether they can generate enough caspase
3 directly or whether they depend upon the Bcl-2-inhibitable
step of mitochondrial ampli¢cation [45].
A second pathway of caspase activation exists and is acti-
vated in response to a variety of cellular stresses, including
DNA damage, protein kinase inhibition, and loss of survival
signaling. In this pathway, termed the mitochondrial pathway,
a pro-apoptotic member of the Bcl-2 family, such as Bax or
Bid, associates with the mitochondria and directs the dissoci-
ation and eventual release of cytochrome c to the cytosol,
where it can associate with another key factor, Apaf-1 [46].
Apaf-1 binds cytochrome c, dATP or ATP, and forms a large
(V700 kDa) multimeric complex, termed the apoptosome,
which also includes molecules of caspase 9 and 3 [47]. Caspase
9 is activated when bound to Apaf-1, where it processes cas-
pase 3 to its active form [48].
While caspases are abundant in the cytoplasm of trans-
formed cell lines, it appears that caspase 9 may be restricted
to the mitochondria in neurons and cardiomyocytes [49]. Cas-
pases and another pro-apoptotic molecule, AIF, are released
from mitochondria along with cytochrome c in response to
stimuli that induce the permeability transition [50]. Recently,
another mitochondrial factor was identi¢ed, named Smac, for
second mitochondrial activator of caspases [51] or Diablo
(direct IAP binding protein with low pI) [52]. This protein,
which is released from mitochondria along with cytochrome c,
binds to inhibitor of apoptosis proteins (IAPs), thereby low-
ering the threshold for caspase activation. The functional sig-
ni¢cance of mitochondrial caspases remains unclear, other
than to be released from mitochondria during apoptosis. In-
ternal mitochondrial targets of caspases have not been iden-
ti¢ed. Although the opening of the PTP has been noted to be
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downstream of caspase activation, proteolysis of pore constit-
uents has not been reported [53].
5. Insights from parallel systems
Substantial parallels exist between the prototypic system of
Caenorhabditis elegans and more complex mammalian sys-
tems. Developmentally programmed cell death in the nema-
tode has been shown to be controlled by a small number of
genes, all of which have counterparts that are conserved
across evolution [54]. The ced3 gene encodes a protein that
corresponds to caspase 3 [55]. It is activated by association
with the product of ced4, which shares homology with Apaf-1
[56]. Cell death is prevented by the expression of ced9, which
is homologous to Bcl-2 [57]. Based on overexpression studies
in heterologous systems, it has been concluded that CED-9,
which is localized to the mitochondrial membrane, binds
CED-4 and prevents its interaction with CED-3 [58]. Expres-
sion of EGL-1 (mammalian homolog: Bax) displaces CED-4,
permitting apoptosis to proceed [59].
Studies of mammalian homologs have been controversial,
but for the most part have failed to demonstrate an inter-
action between Bcl-2 family members and Apaf-1 [60,61].
Most investigators have concluded that the 700 kDa caspase
activation complex, termed the ‘apoptosome’, forms in the
cytosol [47]. This has been based on immuno£uorescence and
cell fractionation studies that detect most Apaf-1 in the cy-
tosol. While cytochrome c is required for mammalian cas-
pase activation, there is no evidence that it plays a role in C.
elegans. Yet both Bcl-2 and CED-9 are associated with the
mitochondria. Do they simply function to sequester pro-ap-
optotic molecules, or is their role in the cell more complex?
One hint for an additional role for Bcl-2 has been provided
by the observation that Bcl-2 interacts with carnitine palmi-
toyl transferase I (CPT I) in a yeast two-hybrid and in co-
precipitation experiments [62]. Given that carnitine inhibits
caspases [63] and sphingomyelinase [64,65], regulation of the
levels of carnitine and palmitoylcarnitine by CPT I and in-
directly by Bcl-2 could have a signi¢cant in£uence on the
ability of the cell to undergo apoptosis. However, evidence
Fig. 3. Two pathways to caspase activation. In the receptor pathway, caspase 8 is recruited to a death-inducing signal complex (DISC) at the
plasma membrane, after Fas ligand (FasL) binds and aggregates Fas. FADD, a death adapter molecule, recruits procaspase 8, which undergoes
proximity-induced processing. The activated caspase 8 can then proteolytically activate procaspase 3. Various cellular stresses cause a pro-apo-
ptotic Bcl-2 family member (e.g. Bax) to bind to the mitochondrial outer membrane, leading to cytochrome c release. Bcl-2 opposes the e¡ect
of Bax. Apaf-1 binds cytochrome c and dATP or ATP, and recruits caspases to form a large complex (the apoptosome). There is cross-talk be-
tween the pathways, as caspase 8 can cleave Bid to generate the active truncated Bid (tBid), which can bind to mitochondria and direct the re-
lease of cytochrome c.
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for regulation of CPT I by Bcl-2 has not been demon-
strated.
6. Summary
Several mechanisms for cytochrome c release have been
proposed. However, even before cytochrome c has been re-
leased, it has ceased to function in electron transport, leading
to a switch to glycolysis. The cytochrome c that has dissoci-
ated from the electron transport complexes may be available
to interact with other pro-apoptotic molecules sequestered in
the mitochondria. Con£icting evidence concerning interac-
tions between Bcl-2 and Apaf-1, as well as the mitochondrial
localization of caspases, AIF, and perhaps other molecules,
suggests the possibility that the apoptosome may nucleate at
the mitochondrial outer membrane before di¡using into the
cytosol. Mitochondria play a central role in the maintenance
of cell survival through energy production and in the initia-
tion of cell death through the release of multiple death mol-
ecules.
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